Kristiaan Nackaerts
- Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trialBy Nanda Horeweg, Carlijn M. van der Aalst, Rozemarijn Vliegenthart, Yingru Zhao, Xueqian Xie, Ernst Th. Scholten, Willem Mali, Erik Thunnissen, Carla Weenink, Harry J.M. Groen, Jan-Willem J. Lammers, Kristiaan Nackaerts, Joost van Rosmalen, Matthijs Oudkerk and Harry J. de KoningNanda Horeweg1Dept of Public Health, Erasmus MC, Rotterdam2Dept of Pulmonary Medicine, Erasmus MC, RotterdamCarlijn M. van der Aalst1Dept of Public Health, Erasmus MC, RotterdamRozemarijn Vliegenthart3Dept of Radiology, University of Groningen, UMCG, GroningenYingru Zhao3Dept of Radiology, University of Groningen, UMCG, GroningenXueqian Xie3Dept of Radiology, University of Groningen, UMCG, GroningenErnst Th. Scholten4Dept of Radiology, Kennemer Gasthuis, HaarlemWillem Mali5Dept of Radiology, UMCU, UtrechtErik Thunnissen6Dept of Pathology, VUMC, AmsterdamCarla Weenink7Dept of Pulmonary Medicine, Kennemer Gasthuis, HaarlemHarry J.M. Groen8Dept of Pulmonary Medicine, UMCG, GroningenJan-Willem J. Lammers9Dept of Pulmonary Medicine, UMCU, Utrecht, The NetherlandsKristiaan Nackaerts10Dept of Pulmonary Medicine, UZ Gasthuisberg, Leuven, BelgiumJoost van Rosmalen1Dept of Public Health, Erasmus MC, RotterdamMatthijs Oudkerk3Dept of Radiology, University of Groningen, UMCG, GroningenHarry J. de Koning1Dept of Public Health, Erasmus MC, Rotterdam
- Metastatic bronchopulmonary carcinoidBy Filip Triest, Kristiaan Nackaerts and Christophe DoomsFilip TriestInternal Medicine, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, BelgiumKristiaan NackaertsInternal Medicine, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, BelgiumChristophe DoomsInternal Medicine, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium
- Diffusion weighted MR can improve preoperative lung cancer diagnosisBy Johan Coolen, Frederik De Keyzer, Paul De Leyn, Johan Vansteenkiste, Walter De Wever, Herbert De Caluwe, Christophe Dooms, Eric Verbeken, Willy Coosemans, Dirk Vanraemdonck, Yolande Lievens, Christophe Deroose, Vincent Vandecaveye, Kristiaan Nackaerts, Steven Dymarkowski and Johny VerschakelenJohan Coolen1Radiology, University Hospitals AZ Gasthuisberg, Leuven, BelgiumFrederik De Keyzer1Radiology, University Hospitals AZ Gasthuisberg, Leuven, BelgiumPaul De Leyn2Thoracic Surgery, University Hospitals AZ Gasthuisberg, Leuven, BelgiumJohan Vansteenkiste3Pneumology, University Hospitals AZ Gasthuisberg, Leuven, BelgiumWalter De Wever1Radiology, University Hospitals AZ Gasthuisberg, Leuven, BelgiumHerbert De Caluwe2Thoracic Surgery, University Hospitals AZ Gasthuisberg, Leuven, BelgiumChristophe Dooms3Pneumology, University Hospitals AZ Gasthuisberg, Leuven, BelgiumEric Verbeken4Pathology, University Hospitals AZ Gasthuisberg, Leuven, BelgiumWilly Coosemans2Thoracic Surgery, University Hospitals AZ Gasthuisberg, Leuven, BelgiumDirk Vanraemdonck2Thoracic Surgery, University Hospitals AZ Gasthuisberg, Leuven, BelgiumYolande Lievens5Radiotherapy, University Hospitals AZ Gasthuisberg, Leuven, BelgiumChristophe Deroose6Nuclear Medicine, University Hospitals AZ Gasthuisberg, Leuven, BelgiumVincent Vandecaveye1Radiology, University Hospitals AZ Gasthuisberg, Leuven, BelgiumKristiaan Nackaerts3Pneumology, University Hospitals AZ Gasthuisberg, Leuven, BelgiumSteven Dymarkowski1Radiology, University Hospitals AZ Gasthuisberg, Leuven, BelgiumJohny Verschakelen1Radiology, University Hospitals AZ Gasthuisberg, Leuven, Belgium
- Volumetric computer tomography screening for lung cancer: three rounds of the NELSON trialBy Nanda Horeweg, Carlijn M. van der Aalst, Rozemarijn Vliegenthart, Yingru Zhao, Xueqian Xie, Ernst Th. Scholten, Willem Mali, Erik Thunnissen, Carla Weenink, Harry J.M. Groen, Jan-Willem J. Lammers, Kristiaan Nackaerts, Joost van Rosmalen, Matthijs Oudkerk and Harry J. de KoningArticle | Published in 2013 in European Respiratory JournalNanda Horeweg*Dept of Public Health, Erasmus MC, Rotterdam, The Netherlands#Dept of Pulmonary Medicine, Erasmus MC, Rotterdam, The NetherlandsCarlijn M. van der Aalst*Dept of Public Health, Erasmus MC, Rotterdam, The NetherlandsRozemarijn Vliegenthart¶Dept of Radiology, UMCG, Groningen, The NetherlandsYingru Zhao¶Dept of Radiology, UMCG, Groningen, The NetherlandsXueqian Xie¶Dept of Radiology, UMCG, Groningen, The NetherlandsErnst Th. Scholten+Dept of Radiology, Kennemer Gasthuis, Haarlem, The NetherlandsWillem Mali§Dept of Radiology, UMCU, Utrecht, The NetherlandsErik ThunnissenfDept of Pathology, VUMC, Amsterdam, The NetherlandsCarla Weenink**Dept of Pulmonary Medicine, Kennemer Gasthuis, Haarlem, The NetherlandsHarry J.M. Groen##Dept of Pulmonary Medicine, UMCG, Groningen, The NetherlandsJan-Willem J. Lammers¶¶Dept of Pulmonary Medicine, UMCU, Utrecht, The NetherlandsKristiaan Nackaerts++Dept of Pulmonary Medicine, UZ Gasthuisberg, Leuven, BelgiumJoost van Rosmalen*Dept of Public Health, Erasmus MC, Rotterdam, The NetherlandsMatthijs Oudkerk¶Dept of Radiology, UMCG, Groningen, The NetherlandsHarry J. de Koning*Dept of Public Health, Erasmus MC, Rotterdam, The Netherlands
- Volatile organic compounds as an early diagnostic tool for malignant pleural mesotheliomaBy Kevin Lamote, Joris Van Cleemput, Kristiaan Nackaerts and Jan van MeerbeeckKevin Lamote1Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumJoris Van Cleemput1Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumKristiaan Nackaerts1Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumJan van Meerbeeck1Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
- Belgian prospective, multicenter, observational study of patients with malignant pleural mesothelioma treated with pemetrexed plus platinumBy Kristiaan Nackaerts, Marc Lambrechts, Frederique Bustin, Luc Van Zandweghe, Benoît Colinet, Michiel Thomeer, Jean François Rosier, Kees Kraaij and Yulia D'yachkovaKristiaan Nackaerts1Department of Pulmonology, University Hospital Gasthuisberg, Leuven, BelgiumMarc Lambrechts2Department of Pulmonology, St. Maarten General Hospital, Mechelen, BelgiumFrederique Bustin3Department of Pneumology, Hospital La Citadelle, Liège, BelgiumLuc Van Zandweghe4Department of Pneumology, AZ Sint Blasius, Dendermonde, BelgiumBenoît Colinet5Department of Pulmonology, Grand Hôpital de Charleroi, Charleroi, BelgiumMichiel Thomeer6Department of Respiratory Medicine, ZOL, Genk and LCRP Cluster Oncology, University of Hasselt, Diepenbeek, BelgiumJean François Rosier7Radiation Oncology Department, CH Jolimont, La Louvière, BelgiumKees Kraaij8Sr Clinical Research Physician Oncology Benelux, Eli Lilly, Houten, NetherlandsYulia D'yachkova9Project Statistician, Eli Lilly GmbH, Vienna, Austria
- Electronic nicotine delivery systemsBy Kristiaan Nackaerts and Luk JoossensKristiaan Nackaerts1Dept of Respiratory Diseases, KU Leuven – University of Leuven, University Hospitals, Leuven, BelgiumLuk Joossens2Foundation against Cancer, Brussels, Belgium
- ESR/ERS white paper on lung cancer screeningBy Hans-Ulrich Kauczor, Lorenzo Bonomo, Mina Gaga, Kristiaan Nackaerts, Nir Peled, Mathias Prokop, Martine Remy-Jardin, Oyunbileg von Stackelberg and Jean-Paul SculierArticle | Published in 2015 in European Respiratory JournalHans-Ulrich Kauczor1Dept of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany2Translational Lung Research Center, Member of the German Lung Research Center, Heidelberg, GermanyLorenzo Bonomo3Institute of Radiology, A. Gemelli University Hospital, Rome, ItalyMina Gaga47th Respiratory Medicine Dept and Asthma Center, Athens Chest Hospital, Athens, GreeceKristiaan Nackaerts5Dept of Respiratory Diseases/Respiratory Oncology Unit, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, BelgiumNir Peled6Davidoff Cancer Center, Rabin Medical Center, Tel Aviv University, Tel Aviv, IsraelMathias Prokop7Dept of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The NetherlandsMartine Remy-Jardin8Dept of Thoracic Imaging, Hospital Calmette (EA 2694), CHRU et Universite de Lille, Lille, FranceOyunbileg von Stackelberg1Dept of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany2Translational Lung Research Center, Member of the German Lung Research Center, Heidelberg, GermanyJean-Paul Sculier9Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- ESR/ERS white paper on lung cancer screeningBy Hans-Ulrich Kauczor, Lorenzo Bonomo, Mina Gaga, Kristiaan Nackaerts, Nir Peled, Mathias Prokop, Martine Remy-Jardin, Oyunbileg von Stackelberg and Jean-Paul SculierHans-Ulrich Kauczor1Dept of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany2Translational Lung Research Center, Member of the German Lung Research Center, Heidelberg, GermanyLorenzo Bonomo3Institute of Radiology, A. Gemelli University Hospital, Rome, ItalyMina Gaga47th Respiratory Medicine Dept and Asthma Center, Athens Chest Hospital, Athens, GreeceKristiaan Nackaerts5Dept of Respiratory Diseases/Respiratory Oncology Unit, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, BelgiumNir Peled6Davidoff Cancer Center, Rabin Medical Center, Tel Aviv University, Tel Aviv, IsraelMathias Prokop7Dept of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The NetherlandsMartine Remy-Jardin8Dept of Thoracic Imaging, Hospital Calmette (EA 2694), CHRU et Universite de Lille, Lille, FranceOyunbileg von Stackelberg1Dept of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany2Translational Lung Research Center, Member of the German Lung Research Center, Heidelberg, GermanyJean-Paul Sculier9Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- Lung cancer screening white paper: a slippery step forward?By Hans-Ulrich Kauczor, Lorenzo Bonomo, Mina Gaga, Kristiaan Nackaerts, Nir Peled, Mathias Prokop, Martine Remy-Jardin, Oyunbileg von Stackelberg and Jean-Paul SculierHans-Ulrich Kauczor1Dept of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany2Translational Lung Research Center, Member of the German Lung Research Center, Heidelberg, GermanyLorenzo Bonomo3Institute of Radiology, A. Gemelli University Hospital, Rome, ItalyMina Gaga47th Respiratory Medicine Dept and Asthma Center, Athens Chest Hospital, Athens, GreeceKristiaan Nackaerts5Dept of Respiratory Diseases/Respiratory Oncology Unit, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, BelgiumNir Peled6Davidoff Cancer Center, Rabin Medical Center, Tel Aviv University, Tel Aviv, IsraelMathias Prokop7Dept of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The NetherlandsMartine Remy-Jardin8Dept of Thoracic Imaging, Hospital Calmette (EA 2694), CHRU et Universite de Lille, Lille, FranceOyunbileg von Stackelberg1Dept of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany2Translational Lung Research Center, Member of the German Lung Research Center, Heidelberg, GermanyJean-Paul Sculier9Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- Volatile organic compounds increase the likelihood of detecting malignant pleural mesotheliomaBy Kevin Lamote, Matthijs Vynck, Joris Van Cleemput, Olivier Thas, Kristiaan Nackaerts and Jan P. Van MeerbeeckKevin Lamote1Internal Medicine, Ghent University, Ghent, Belgium2Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumMatthijs Vynck3Mathematical Modelling, Statistics and Bioinformatics, Ghent University, Ghent, BelgiumJoris Van Cleemput4Occupational Health Service, Eternit NV, Kapelle-op-den-Bos, BelgiumOlivier Thas3Mathematical Modelling, Statistics and Bioinformatics, Ghent University, Ghent, BelgiumKristiaan Nackaerts5Respiratory Medicine, University Hospital Gasthuisberg, Leuven, BelgiumJan P. Van Meerbeeck2Respiratory Medicine, Ghent University Hospital, Ghent, Belgium6MOCA/Thoraxoncology, Antwerp University Hospital, Edegem, Belgium
- Counting asbestos bodies in bronchoalveolar lavage: A retrospective analysis and literature reviewBy Valerie Nuyts, Hadewijch Vanhooren, Kristiaan Nackaerts and Benoit Nemery de BellevauxValerie Nuyts1Clinical and Experimental Medicine, Laboratory for Respiratory Diseases, Research Unit of Lung Toxicology, KU Leuven-University of Leuven, Leuven, Brabant BelgiumHadewijch Vanhooren1Clinical and Experimental Medicine, Laboratory for Respiratory Diseases, Research Unit of Lung Toxicology, KU Leuven-University of Leuven, Leuven, Brabant BelgiumKristiaan Nackaerts2Respiratory Diseases, Respiratory Oncology Unit, KU Leuven-University of Leuven, University Hospitals Leuven, Leuven, Brabant BelgiumBenoit Nemery de Bellevaux1Clinical and Experimental Medicine, Laboratory for Respiratory Diseases, Research Unit of Lung Toxicology, KU Leuven-University of Leuven, Leuven, Brabant Belgium
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
